Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ? (2017)
- Authors:
- Autor USP: HALLAK, JAIME EDUARDO CECILIO - FMRP
- Unidade: FMRP
- DOI: 10.1017/S003329171600307X
- Assunto: ESQUIZOFRENIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Psychological Medicine
- ISSN: 0033-2917
- Volume/Número/Paginação/Ano: v. 47, n. 5, p. 981-982, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MAIA-DE-OLIVEIRA, João Paulo et al. Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ?. Psychological Medicine, v. 47, n. 5, p. 981-982, 2017Tradução . . Disponível em: https://doi.org/10.1017/S003329171600307X. Acesso em: 15 fev. 2026. -
APA
Maia-de-Oliveira, J. P., Baker, G. B., Dursun, S. M., & Hallak, J. E. C. (2017). Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ? Psychological Medicine, 47( 5), 981-982. doi:10.1017/S003329171600307X -
NLM
Maia-de-Oliveira JP, Baker GB, Dursun SM, Hallak JEC. Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ? [Internet]. Psychological Medicine. 2017 ; 47( 5): 981-982.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1017/S003329171600307X -
Vancouver
Maia-de-Oliveira JP, Baker GB, Dursun SM, Hallak JEC. Sodium nitroprusside for schizophrenia. [Carta]: could methodological variables account for the different results obtained ? [Internet]. Psychological Medicine. 2017 ; 47( 5): 981-982.[citado 2026 fev. 15 ] Available from: https://doi.org/10.1017/S003329171600307X - Psychotic syndrome secondary to meningioma treated with a low dose of olanzapine. [Carta]
- Disorganized symptoms predicted worse functioning outcome in schizophrenia patients with established illness
- Transtorno de pânico e outros medicamentos
- Psychedelics and Personality
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- Nitric oxide’s involvement in the spectrum of psychotic disorders
- Effects of the natural β-carboline alkaloid harmine, a main constituent of Ayahuasca, in memory and in the hippocampus: a systematic literature review of preclinical studies
- An overview of animal models related to schizophrenia
- Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
- Cognition in at-risk mental states for psychosis
Informações sobre o DOI: 10.1017/S003329171600307X (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
